Tesamorelin

Tesamorelin is a synthetic peptide that functions as an analog of growth hormone–releasing hormone (GHRH). It is FDA-approved for the treatment of HIV-associated lipodystrophy, a condition marked by abnormal fat distribution, particularly the buildup of excess abdominal fat. By stimulating the pituitary gland to release growth hormone, Tesamorelin promotes lipolysis and helps reduce visceral adipose tissue.